Overview and Scope
Nucleic acid labeling refers to the process of introducing detectable tags or markers into DNA or RNA molecules. These tags can be used to visualize and detect specific nucleic acid sequences or to track their presence, location, or activity in various experimental or diagnostic applications.
Sizing and Forecast
The nucleic acid labeling market size has grown strongly in recent years. It will grow from $2.34 billion in 2023 to $2.55 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increased healthcare expenditure, rise in r&d spending, increased genomics research and disease diagnosis, increased demand for personalized medicine, healthcare infrastructure.
The nucleic acid labeling market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to rising health awareness among people, growing penetration of key global players, increasing focus on patient-centered approaches, growing biotechnology sector, increasing use of dna sequencing. Major trends in the forecast period include advancements in tools for synthetic biology, advancements in labeling techniques, development of novel labeling techniques, innovative fluorescent dyes, integration of new labeling technologies in research and therapeutics.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Segmentation & Regional Insights
The nucleic acid labeling market covered in this report is segmented –
1) By Product Type: Kits, Reagents, Instruments
2) By Labeling Type: Radioisotope Or Radioactive Labels, Non-Radioactive Labels
3) By Method: Enzyme-Based, Chemical-Based
4) By Application: DNA Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Microarrays, Blotting, In Situ Hybridization, Other Applications
5) By End User: Hospitals Or Clinics, Diagnostic Centers, Other End Users
North America was the largest region in the nucleic acid labeling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12647&type=smp
Major Driver Impacting Market Growth
The rise in infectious diseases is expected to propel the growth of the nucleic acid labeling market going forward. Infectious diseases are conditions caused by organisms, usually microscopic, such as parasites, fungi, viruses, and bacteria that are transmitted from one individual to another through indirect or direct contact. Nucleic acid labeling techniques offer improved specificity, sensitivity, multiplexing capability, visualization, real-time monitoring, and automation for the detection of infectious diseases such as tuberculosis, hepatitis, and gonorrhea. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Additionally, tuberculosis (TB) incidence increased slightly in 2022 (2.5 incidents per 100,000 people). Therefore, the rise in infectious diseases propels the growth of the nucleic acid labeling market.
Key Industry Players
Major companies operating in the nucleic acid labeling market report are General Electric Company, F. Hoffman-La Roche AG, Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, Kaneka Eurogentec SA, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences.
The nucleic acid labeling market report table of contents includes:
1. Executive Summary
2. Nucleic Acid Labeling Market Characteristics
3. Nucleic Acid Labeling Market Trends And Strategies
4. Nucleic Acid Labeling Market – Macro Economic Scenario
5. Global Nucleic Acid Labeling Market Size and Growth
.
.
.
32. Global Nucleic Acid Labeling Market Competitive Benchmarking
33. Global Nucleic Acid Labeling Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Nucleic Acid Labeling Market
35. Nucleic Acid Labeling Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
